The Value Added Medicines Group Participated for the First Time at the 22nd Congress of the European Association of Hospital Pharmacists Which Took Place 22-24 March in Cannes.

A special satellite  symposium was organized on “Value added medicines – What value repurposed medicines might bring to hospital pharmacists”. Christoph Stoller, chair of the Value Added Medicines Group, chaired the session and opened with a short introduction to value added medicines. Professor Doctor Stephan Krähenbuhl, from the University Hospital of Basel, explained to the audience the importance of continuous innovation on existing molecules for the physician perspective. He presented several examples of repurposed medicines which benefited him in his work. Minodora Voiculescu, Medical Advisor at Fresenius Kabi, closed the presentations by focussing on the existing barriers for value added medicines in Europe and how hospital pharmacists can ensure their availability.